These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 27320932

  • 1. [Treatment for rheumatoid arthritis by chemokine blockade].
    Nanki T.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):172-80. PubMed ID: 27320932
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE.
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [Abstract] [Full Text] [Related]

  • 3. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
    Sucur A, Jajic Z, Artukovic M, Matijasevic MI, Anic B, Flegar D, Markotic A, Kelava T, Ivcevic S, Kovacic N, Katavic V, Grcevic D.
    Arthritis Res Ther; 2017 Jun 15; 19(1):142. PubMed ID: 28619088
    [Abstract] [Full Text] [Related]

  • 4. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
    Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP.
    Ann Rheum Dis; 2006 Mar 15; 65(3):294-300. PubMed ID: 16107514
    [Abstract] [Full Text] [Related]

  • 5. Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.
    Lebre MC, Vergunst CE, Choi IY, Aarrass S, Oliveira AS, Wyant T, Horuk R, Reedquist KA, Tak PP.
    PLoS One; 2011 Mar 15; 6(7):e21772. PubMed ID: 21747955
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
    Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, Feldmann M, Maini RN.
    Arthritis Rheum; 2000 Jan 15; 43(1):38-47. PubMed ID: 10643698
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
    Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, Godson C, Mullan R, FitzGerald O, Bresnihan B, Pitzalis C, Veale DJ, Fearon U.
    J Immunol; 2010 Jun 01; 184(11):6427-37. PubMed ID: 20435930
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis.
    Armas-González E, Domínguez-Luis MJ, Díaz-Martín A, Arce-Franco M, Castro-Hernández J, Danelon G, Hernández-Hernández V, Bustabad-Reyes S, Cantabrana A, Uguccioni M, Díaz-González F.
    Arthritis Res Ther; 2018 Jun 07; 20(1):114. PubMed ID: 29880013
    [Abstract] [Full Text] [Related]

  • 13. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
    Yano R, Yamamura M, Sunahori K, Takasugi K, Yamana J, Kawashima M, Makino H.
    Acta Med Okayama; 2007 Apr 07; 61(2):89-98. PubMed ID: 17471309
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemokine inhibition in inflammatory arthritis.
    Tak PP.
    Best Pract Res Clin Rheumatol; 2006 Oct 07; 20(5):929-39. PubMed ID: 16980215
    [Abstract] [Full Text] [Related]

  • 17. The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue.
    Shadidi KR, Aarvak T, Henriksen JE, Natvig JB, Thompson KM.
    Scand J Immunol; 2003 Feb 07; 57(2):192-8. PubMed ID: 12588667
    [Abstract] [Full Text] [Related]

  • 18. JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model.
    Kim B, Lee JH, Jin WJ, Kim HH, Ha H, Lee ZH.
    Eur J Pharmacol; 2018 Mar 15; 823():1-10. PubMed ID: 29378189
    [Abstract] [Full Text] [Related]

  • 19. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8.
    Hayashida K, Nanki T, Girschick H, Yavuz S, Ochi T, Lipsky PE.
    Arthritis Res; 2001 Mar 15; 3(2):118-26. PubMed ID: 11178119
    [Abstract] [Full Text] [Related]

  • 20. Chemokine receptor expression in rat adjuvant-induced arthritis.
    Haas CS, Martinez RJ, Attia N, Haines GK, Campbell PL, Koch AE.
    Arthritis Rheum; 2005 Dec 15; 52(12):3718-30. PubMed ID: 16320322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.